What about pleiotropic modifiers of preprocedural pro-inflammatory and pro-oxidant milieu in patients undergoing drug eluting stent implantation?
The exact pathophysiological mechanisms of coronary in-stent restenosis (ISR) has not yet been fully elucidated. Inflammation is known as the most commonly encountered pathway. Medications for cardiometabolic risk factors as the modifiers of preprocedural pro-inflammatory and pro-oxidant milieu shou...
Saved in:
Main Author: | Uğur Canpolat (Author) |
---|---|
Format: | Book |
Published: |
KARE Publishing,
2015-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical results of everolimus-eluting stents and sirolimus-eluting stents in patients undergoing percutaneous coronary intervention
by: Iraj Jafaripour, et al.
Published: (2023) -
The value of peripheral blood eosinophil count in predicting in-stent restenosis in patients with stable angina pectoris undergoing drug eluting stenting
by: Hajizadeh Reza, et al.
Published: (2017) -
Severe complication of early cessation of therapy with ticagrelor after drug-eluting stent implantation
by: Natasha Ahmed, et al.
Published: (2021) -
PREPARATIONS PRO-IMPLANT VERSUS PRO-PROSTHETIC
by: Catalina Mihaela Holban Cioloca, et al.
Published: (2016) -
Introductory Editorial: Drug-Eluting Stents or Drug-Eluting Grafts? Insights from Proteomic Analysis
by: Spadaccio Cristiano, et al.
Published: (2016)